Evandro de Azambuja

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 41

Top Topics

Systematic Review

Early Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

NPJ breast cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer research and treatment

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Arecco, Roberto Borea, Isotta Martha Magaton, Kristina Janković, Elene Mariamizde, Mihaela Stana, Graziana Scavone, Silvia Ottonello, Stefano Spinaci, Carlo Genova, Evandro de Azambuja, Matteo Lambertini
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert review of anticancer therapy (2024)
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P Winer, Jonas Bergh, Richard D Gelber, Eleonora Restuccia, Young-Hyuck Im, Chiun-Sheng Huang, Florence Dalenc, Isabel Calvo, Marion Procter, Carmela Caballero, Emma Clark, Alice Raimbault, Robin McConnell, Estefania Monturus, Evandro de Azambuja, Henry Leonidas Gómez, Judith M Bliss, Giuseppe Viale, Jose Bines, Martine J Piccart, null null
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D Gelber, Nancy Van Damme, Lien van Walle, Arlindo R Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Fran Ois P Duhoux, Hans P M W Wildiers, Carmela Caballero, Ahmad Awada, Martine J Piccart, Kevin Punie, Evandro de Azambuja
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium. Breast cancer research and treatment (2024)
Luca Arecco, Roberto Borea, Isotta Martha Magaton, Kristina Janković, Elene Mariamizde, Mihaela Stana, Graziana Scavone, Silvia Ottonello, Stefano Spinaci, Carlo Genova, Evandro de Azambuja, Matteo Lambertini
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer. Expert review of anticancer therapy 24 (9) (2024)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D Gelber, Nancy Van Damme, Lien van Walle, Arlindo R Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Fran Ois P Duhoux, Hans P M W Wildiers, Carmela Caballero, Ahmad Awada, Martine J Piccart, Kevin Punie, Evandro de Azambuja
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium. Breast cancer research and treatment (2023)
Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini
Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elisa Agostinetto, Luca Arecco, Evandro de Azambuja
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? Oncology and therapy (2023)
Diogo Martins-Branco, Marie Kassapian, Veronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni, Charitini Andriakopoulou, Sarra El-Abed, Susan L Ellard, Miguel Izquierdo, Malou Vicente, Saranya Chumsri, Martine J Piccart, Alvaro Moreno-Aspitia, Ann Søegaard Knop, Janine Lombard, Evandro de Azambuja
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study. Breast cancer research and treatment (2023)
Diogo Martins-Branco, Guilherme Nader Marta, Ana Tečić Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Angela Loizidou, Karen Willard-Gallo, Chloe Spilleboudt, Ahmad Awada, Martine J Piccart, Evandro de Azambuja
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis. Journal of cancer research and clinical oncology (2022)
Matteo Lambertini, Shona Fielding, Sibylle Loibl, Wolfgang Janni, Emma Clark, Maria Alice Franzoi, Debora Fumagalli, Carmela Caballero, Luca Arecco, Sharon Salomoni, Noam F Ponde, Francesca Poggio, Hee Jeong Kim, Cynthia Villarreal-Garza, Olivia Pagani, Shani Paluch-Shimon, Alberto Ballestrero, Lucia Del Mastro, Martine Piccart, Jose Bines, Ann H Partridge, Evandro de Azambuja
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy. Journal of the National Cancer Institute 114 (8) (2022)
Elisa Agostinetto, Agnese Losurdo, Guilherme Nader Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja, Matteo Lambertini
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert opinion on investigational drugs 31 (6) (2022)
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bliss, Judith Kroep, Marco Colleoni, Fausto Petrelli, Lucia Del Mastro, Alvaro Moreno-Aspitia, Martine Piccart, Marianne Paesmans, Evandro de Azambuja, Matteo Lambertini
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer 8 (1) (2022)
Bolivar Arboleda-Osorio, Rupert Bartsch, Evandro de Azambuja, Erika Paige Hamilton, Nadia Harbeck, Jennifer R Klemp, Michael Knauer, Sherko Kuemmel, Reshma L Mahtani, Florian Scotté, Cynthia Villarreal Garza, Antonio Wolff
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel. The oncologist 27 (9) (2022)
Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer. Cancers 14 (21) (2022)
Mariana Brandão, Christian Maurer, Patricia Klarmann Ziegelmann, Noam Falbel Pondé, Arlindo R Ferreira, Samuel Martel, Martine Piccart, Evandro de Azambuja, Márcio Debiasi, Matteo Lambertini
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis. ESMO open 5 (4) (2021)
Kamal S Saini, Kevin Punie, Chris Twelves, Stefanella Bortini, Evandro de Azambuja, Steven Anderson, Carmen Criscitiello, Ahmad Awada, Sherene Loi
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. Expert opinion on biological therapy 21 (7) (2021)
Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M Rubinstein, Prudence A Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. NPJ breast cancer 7 (1) (2021)
David Venet, Mattia Rediti, Marion Maetens, Debora Fumagalli, David N Brown, Samira Majjaj, Roberto Salgado, Lajos Pusztai, Nadia Harbeck, Sarra El-Abed, Yingbo Wang, Cristina Saura, Henry L Gómez, Vladimir Fedorovich Semiglazov, Evandro de Azambuja, Jens Huober, Paolo G Nuciforo, Serena Di Cosimo, Martine Piccart, Sherene Loi, Françoise Rothé, Christos Sotiriou
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Martine J Piccart, Marion Procter, Debora Fumagalli, Evandro de Azambuja, Emma Clark, Michael S Ewer, Eleonora Restuccia, Guy Jerusalem, Susan F Dent, Linda Reaby, Hervé R Bonnefoi, Ian E Krop, Tsang-Wu Liu, Tadeusz Pieńkowski, Masakazu Toi, Nicholas Wilcken, Michael Andersson, Young-Hyuck Im, Ling Ming Tseng, Hans-Joachim Lueck, Marco Colleoni, Estefania Monturus, Mihaela Sicoe, Sébastien Guillaume, Jose Bines, Richard D Gelber, Giuseppe Viale, Christoph Thomssen, null null
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Daniel Eiger, Mariana Brandão, Evandro de Azambuja
Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer. ESMO open 5 (2) (2021)
Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, Marta Perachino, Richard A Anderson, Evandro de Azambuja, Philip D Poorvu, Hee Jeong Kim, Cynthia Villarreal Garza, Barbara Pistilli, Ines Vaz Luis, Cristina Saura, Kathryn J Ruddy, Maria Alice B Franzoi, Chiara Sertoli, Marcello Ceppi, Hatem A Azim, Frédéric Amant, Isabelle Demeestere, Lucia Del Mastro, Ann H Partridge, Olivia Pagani, Fedro Alessandro Peccatori
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Gilberto Morgan, Evandro de Azambuja, Kevin Punie, Felipe Ades, Kathrin Heinrich, Nicola Personeni, Ramy Rahmé, Roberto Ferrara, Kevin Pels, Marina Garassino, Michael von Bergwelt-Baildon, Gilberto Lopes, Fabrice Barlesi, Toni K Choueiri, Howard Burris, Solange Peters
OncoAlert Round Table Discussions: The Global COVID-19 Experience. JCO global oncology 7 (2021)
Daniel Eiger, Maria Alice Franzoi, Noam Pondé, Mariana Brandão, Claudia de Angelis, Melanie Schmitt Nogueira, Quentin de Hemptinne, Evandro de Azambuja
Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials. ESMO open 5 (1) (2021)
Elisa Agostinetto, Mattia Rediti, Danai Fimereli, Véronique Debien, Martine Piccart, Philippe Aftimos, Christos Sotiriou, Evandro de Azambuja
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis. Cancers 13 (11) (2021)
Elisa Agostinetto, Daniel Eiger, Kevin Punie, Evandro de Azambuja
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer. Current oncology reports 23 (5) (2021)
Andrew N J Tutt, Judy E Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M Domchek, Karen A Gelmon, Simon J Hollingsworth, Larissa A Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M Suga, Zhimin Shao, Andrew W Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A Ganz, Peter C Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita Schmutzler, Guenther G Steger, Joseph P Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R Lakhani, Greg Yothers, Christine Campbell, Charles E Geyer, null null
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. The New England journal of medicine 384 (25) (2021)
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E Robson, Justin Ndozeng, Andrea Gombos, Eva Ciruelos Gil, Evandro de Azambuja, Giuseppe Viale, Elsemieke D Scheepers, Curigliano Giuseppe, Judith M Bliss, Jorge S Reis-Filho, Marco Colleoni, Marija Balić, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans P M W Wildiers, Angel L Guerrero-Zotano, Peter S Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Ásgerdur Sverrisdóttir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E Davidson, Oskar Th Johannsson, Philippe L Bedard, Sherene Loi, Susan Knox, David A Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandão, Andrea Vingiani, Carmela Caballero, Florentine S Hilbers, Lucy R Yates, Matteo Benelli, David Venet, Martine J Piccart
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. Cancer discovery 11 (11) (2021)
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, Chiara Gargiuli, Loris De Cecco, Evandro de Azambuja, Debora Fumagalli, Christos Sotiriou, Nadia Harbeck, Miguel Izquierdo, Paolo G Nuciforo, Jens Huober, Vera Cappelletti, Saverio Cinieri, Martine Piccart, Maria Grazia Daidone, Giancarlo Pruneri, Mario Paolo Colombo, Elda Tagliabue, Paolo Verderio, Serena Di Cosimo
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Pena, Florentine S Hilbers, Evandro de Azambuja, Michael Untch, Lajos Pusztai, Kathleen Pritchard, Paolo G Nuciforo, Anne Vincent-Salomon, Fraser Symmans, Giovanni Apolone, Filippo G de Braud, Marilena V Iorio, Paolo Verderio, Maria Grazia Daidone
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. International journal of molecular sciences 21 (4) (2020)
Evandro de Azambuja, Dario Trapani, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Carmen Criscitiello, Philip Poortman, Michael Gnant, Serena Di Cosimo, Javier Cortes, Fatima Cardoso, Shani Paluch-Shimon, Curigliano Giuseppe
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO open 5 (Suppl 3) (2020)
Daniel Eiger, Marcio Wagner, Noam Falbel Pondé, Melanie Schmitt Nogueira, Laurence Buisseret, Evandro de Azambuja
The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC). Acta oncologica (Stockholm, Sweden) 59 (6) (2020)
Rafael Caparica, Claudia De Angelis, Ângelo Fêde, Gustavo Werutsky, Evandro de Azambuja
Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas? Expert review of anticancer therapy 20 (7) (2020)
Evandro de Azambuja, Noam Ponde, Marion Procter, Priya Rastogi, Reena S Cecchini, Matteo Lambertini, Karla Ballman, Alvaro Moreno Aspitia, Dimitrios Zardavas, Lise Roca, Richard D Gelber, Martine Piccart-Gebhart, Thomas Suter
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials. Breast cancer research and treatment 179 (1) (2019)
Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Paola Tiberio, Marilena V Iorio, Florentine S Hilbers, Evandro de Azambuja, Lorena de la Peña, Miguel Izquierdo, Jens Huober, José Baselga, Martine Piccart, Filippo G de Braud, Giovanni Apolone, Paolo Verderio, Maria Grazia Daidone
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (13) (2019)
Noam Pondé, Evandro de Azambuja
PERSEPHONE - implications for clinical practice in 2019. Nature reviews. Clinical oncology 16 (11) (2019)
Martin Filipits, Urania Dafni, Michael Gnant, Varvara Polydoropoulou, Margaret Hills, Astrid Kiermaier, Evandro de Azambuja, Denis Larsimont, Federico Rojo, Giuseppe Viale, Masakazu Toi, Nadia Harbeck, Kathleen I Prichard, Richard D Gelber, Phuong Dinh, Dimitrios Zardavas, Brian Leyland-Jones, Martine J Piccart-Gebhart, Mitch Dowsett, null null
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (13) (2018)
Noam Ponde, Ian Bradbury, Matteo Lambertini, Michael Ewer, Christine Campbell, Helene Ameels, Dimitrios Zardavas, Serena Di Cosimo, José Baselga, Jens Huober, Miguel Izquierdo, Debora Fumagalli, Ivana Bozovic-Spasojevic, Marion Maetens, Nadia Harbeck, Lajos Pusztai, Michael Berghorn, Young-Hyuck Im, Manuel Ruiz Borrego, Dar-Ren Chen, Richard Rodeheffer, Martine Piccart, Thomas Suter, Evandro de Azambuja
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast cancer research and treatment 168 (3) (2017)